0001225208-21-010901.txt : 20210727
0001225208-21-010901.hdr.sgml : 20210727
20210727202848
ACCESSION NUMBER: 0001225208-21-010901
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210727
FILED AS OF DATE: 20210727
DATE AS OF CHANGE: 20210727
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Scanlon Meghan
CENTRAL INDEX KEY: 0001801586
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11083
FILM NUMBER: 211119461
MAIL ADDRESS:
STREET 1: C/O BOSTON SCIENTIFIC CORPORATION
STREET 2: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP
CENTRAL INDEX KEY: 0000885725
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 042695240
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
BUSINESS PHONE: 508-683-4000
MAIL ADDRESS:
STREET 1: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
4
1
doc4.xml
X0306
4
2021-07-27
0000885725
BOSTON SCIENTIFIC CORP
BSX
0001801586
Scanlon Meghan
300 BOSTON SCIENTIFIC WAY
MARLBOROUGH
MA
01752-1234
1
SVP,Pres,Urology Pelvic Health
Common Stock
2021-07-27
4
M
0
13850.0000
23.4100
A
32992.0000
D
Common Stock
2021-07-27
4
S
0
13850.0000
45.0100
D
19142.0000
D
Stock Option (Right to Buy)
23.4100
2021-07-27
4
M
0
13850.0000
0.0000
D
2026-07-01
Common Stock
13850.0000
0.0000
D
The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan.
Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.
Represents the weighted average sale price. These shares were sold in multiple transactions at $45.00 and $45.02. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Grant to the reporting person of an option to purchase 13,850 shares of common stock vesting in four equal annual installments beginning on July 1, 2017, the first anniversaryof the date of grant.
/s/ Vance R. Brown, Attorney-in-fact
2021-07-27